| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |